Antonios Anastasiadis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Antonios Anastasiadis has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Helen Giamarellou
1(st) Department of Internal Medicine & Infectious Diseases, Hygeia General Hospital, Athens, Greece
2 shared publications A Andreopoulos
1 shared publicationA. G. Andreopoulos
Department of Chemical Engineering, National Technical University of Athens, Zografou Athens, Greece
1 shared publicationAaron Venouziou
Karditsa District General Hospital, Orthopaedic Department, Karditsa, Greece
1 shared publicationAndreas Andreopoulos
Fourth Department of Internal Medicine, Athens Medical School, Sismanoglion General Hospital,1 First Department of Propedeutic Medicine, Athens Medical School,2 and Department of Orthopaedics,3 Laiko General Hospital, and Department of Chemical Engineering, Athens Polytechnique School,4 Athens, Greece
1 shared publicationE Dounis
Department of Orthopaedics, Laiko General Hospital, Athens, Greece
1 shared publication
Latest Publications
- Open Access
- 31 January 2018
- Published by Wiley in Case Reports in Orthopedics
- Vol. 2018 (1) , 2070564
Open Reduction and Internal Fixation of a Proximal Femoral Shaft Fracture in a Patient with Bilateral Congenital Hip Disease
We present a rare case of a femoral shaft fracture in a 74‐year‐old woman with a preexisting untreated bilateral congenital hip dislocation and with concomitant leg length discrepancy. Because of the marked deformity of the upper femur, a derivative of the congenital hip disease, an open reduction and internal fixation was performed, with the use of an anatomic femur plate originally designed for the treatment of periprosthetic fractures. The patient was treated successfully and returned to her previous status of activity. The management of a femoral fracture in the presence of ipsilateral hip disease is a challenging issue. The surgical treatment choice in such cases has to be individualized, taking into consideration several anatomic and medical parameters.
- 31 January 2018
- Published by Wiley in Case Reports in Orthopedics
- Vol. 2018 (1) , 2070564
Open AccessOpen Reduction and Internal Fixation of a Proximal Femoral Shaft Fracture in a Patient with Bilateral Congenital Hip Disease
We present a rare case of a femoral shaft fracture in a 74‐year‐old woman with a preexisting untreated bilateral congenital hip dislocation and with concomitant leg length discrepancy. Because of the marked deformity of the upper femur, a derivative of the congenital hip disease, an open reduction and internal fixation was performed, with the use of an anatomic femur plate originally designed for the treatment of periprosthetic fractures. The patient was treated successfully and returned to her previous status of activity. The management of a femoral fracture in the presence of ipsilateral hip disease is a challenging issue. The surgical treatment choice in such cases has to be individualized, taking into consideration several anatomic and medical parameters.
- 12 March 2009
- Published by SAGE Publications in Journal of Hand Surgery (European Volume)
- Vol. 34 (2) , 282-283
Traumatic dynamic anterior instability of the trapeziometacarpal joint
- 12 March 2009
- Published by SAGE Publications in Journal of Hand Surgery (European Volume)
- Vol. 34 (2) , 282-283
Traumatic dynamic anterior instability of the trapeziometacarpal joint
- 1 March 1999
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (3) , 714-716
Lactic Acid Polymers as Biodegradable Carriers of Fluoroquinolones: An In Vitro Study
A biodegradable polymer of dl -dilactide that facilitates release of ciprofloxacin or pefloxacin at levels exceeding MICs for the causative microorganisms of chronic osteomyelitis is described. Duration and peak of release were found to depend on the molecular weight of the polymer. Its characteristics make it promising for treating chronic bone infections.
- 1 March 1999
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 43 (3) , 714-716
Lactic Acid Polymers as Biodegradable Carriers of Fluoroquinolones: An In Vitro Study
A biodegradable polymer of dl -dilactide that facilitates release of ciprofloxacin or pefloxacin at levels exceeding MICs for the causative microorganisms of chronic osteomyelitis is described. Duration and peak of release were found to depend on the molecular weight of the polymer. Its characteristics make it promising for treating chronic bone infections.
- 1 April 1996
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 10 (4) , 338-347
In Vitro Release of New Quinolones from Biodegradable Systems: A Comparative Study
A new biodegradable delivery system based on low molecular weight poly(lactic acid) has been formualted, with potential application in the sustained antibiotic release against bone infection. The in vitro release of two new quinolones (ofloxacin and ciprofloxacin) from the biodegradable matrix showed that the delivery of ofloxacin from the matrix lasted fifty-six days, whereas that of ciprofloxacin lasted fifty-one days. In both cases, release is controlled by the drug diffusion and the matrix degradation, the latter being the most critical factor. The obtained concentration levels are well above the Minimum Inhibitory Concentration (MIC) against the major causative bacteria of osteomyelitis. This fact in combination with the good reproducibility of measurements indicated that the system studied could be of value for the preparation of implantable controlled release systems for treatment of diseases in the bone system.
- 1 April 1996
- Published by SAGE Publications in Journal of Biomaterials Applications
- Vol. 10 (4) , 338-347
In Vitro Release of New Quinolones from Biodegradable Systems: A Comparative Study
A new biodegradable delivery system based on low molecular weight poly(lactic acid) has been formualted, with potential application in the sustained antibiotic release against bone infection. The in vitro release of two new quinolones (ofloxacin and ciprofloxacin) from the biodegradable matrix showed that the delivery of ofloxacin from the matrix lasted fifty-six days, whereas that of ciprofloxacin lasted fifty-one days. In both cases, release is controlled by the drug diffusion and the matrix degradation, the latter being the most critical factor. The obtained concentration levels are well above the Minimum Inhibitory Concentration (MIC) against the major causative bacteria of osteomyelitis. This fact in combination with the good reproducibility of measurements indicated that the system studied could be of value for the preparation of implantable controlled release systems for treatment of diseases in the bone system.
- 1 January 1996
- Vol. 55 (1) , 16-9
Sustained release of fleroxacin in vitro from lactic acid polymer.
The time-delayed release of fleroxacin, a newer fluoroquinolone, from a mixture of racemic D-L-Lactic acid is reviewed. Ten in vitro experiments for each fleroxacin concentration of 1% and 10%, were performed. Pre-formed D-L-Lactic acid, plus fleroxacin clots were preserved in sterile 1 cm diameter tubes with one ml of nutrient broth at 37 degrees C until they were fully disintegrated. Every 24 hours the tubes were sampled and replaced by standard broth volumes. Fleroxacin levels were measured by a microbiological method. The release of fleroxacin impregnated in D-L-Lactic acid clots in these two concentrations (1% and 10%) is very promising; the levels obtained over a two month period were much higher than the minimum bacterial concentration of the expected pathogens implicated in bone infections.
- 1 January 1996
- Vol. 55 (1) , 16-9
Sustained release of fleroxacin in vitro from lactic acid polymer.
The time-delayed release of fleroxacin, a newer fluoroquinolone, from a mixture of racemic D-L-Lactic acid is reviewed. Ten in vitro experiments for each fleroxacin concentration of 1% and 10%, were performed. Pre-formed D-L-Lactic acid, plus fleroxacin clots were preserved in sterile 1 cm diameter tubes with one ml of nutrient broth at 37 degrees C until they were fully disintegrated. Every 24 hours the tubes were sampled and replaced by standard broth volumes. Fleroxacin levels were measured by a microbiological method. The release of fleroxacin impregnated in D-L-Lactic acid clots in these two concentrations (1% and 10%) is very promising; the levels obtained over a two month period were much higher than the minimum bacterial concentration of the expected pathogens implicated in bone infections.